$180,000 of HACKENSACK MERIDIAN HEALTH lobbying was just disclosed, from Q1 of 2026, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Congressional directed spending requests AI Organ Donation and Transplant Graduate Medical Education AI Organ Donation and Transplant 340B Graduate Medical Education 340B"
You can find more data on corporate lobbying on Quiver Quantitative.
MRBK Hedge Fund Activity
We have seen 51 institutional investors add shares of MRBK stock to their portfolio, and 21 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- WICK CAPITAL PARTNERS, LLC removed 140,036 shares (-96.9%) from their portfolio in Q4 2025, for an estimated $2,461,832
- BANC FUNDS CO LLC removed 131,919 shares (-29.1%) from their portfolio in Q4 2025, for an estimated $2,319,136
- ATEGRA CAPITAL MANAGEMENT, LLC removed 54,671 shares (-13.4%) from their portfolio in Q4 2025, for an estimated $961,116
- CITADEL ADVISORS LLC removed 54,238 shares (-75.8%) from their portfolio in Q4 2025, for an estimated $953,504
- AMERICAN CENTURY COMPANIES INC added 49,757 shares (+57.8%) to their portfolio in Q4 2025, for an estimated $874,728
- FOURTHSTONE LLC added 49,561 shares (+4.6%) to their portfolio in Q4 2025, for an estimated $871,282
- RENAISSANCE TECHNOLOGIES LLC removed 39,700 shares (-63.4%) from their portfolio in Q4 2025, for an estimated $697,925
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
MRBK Price Targets
Multiple analysts have issued price targets for $MRBK recently. We have seen 2 analysts offer price targets for $MRBK in the last 6 months, with a median target of $22.0.
Here are some recent targets:
- Russell Gunther from DA Davidson set a target price of $22.0 on 02/04/2026
- Manuel Navas from Piper Sandler set a target price of $22.0 on 02/03/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
